 Bennett Davenport
Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 8 | 2021 | 660 | 2.810 |
Why?
| | Immunologic Memory | 5 | 2020 | 310 | 2.210 |
Why?
| | Chikungunya virus | 7 | 2022 | 51 | 1.830 |
Why?
| | Lymphocytic choriomeningitis virus | 4 | 2019 | 22 | 1.750 |
Why?
| | Chikungunya Fever | 6 | 2022 | 53 | 1.660 |
Why?
| | Chemokines | 4 | 2020 | 237 | 1.080 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2021 | 185 | 1.060 |
Why?
| | Lymph Nodes | 4 | 2021 | 484 | 0.970 |
Why?
| | Lymphocytic Choriomeningitis | 2 | 2018 | 13 | 0.900 |
Why?
| | Arenaviridae Infections | 2 | 2019 | 8 | 0.870 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 77 | 0.850 |
Why?
| | Alphavirus Infections | 4 | 2021 | 40 | 0.810 |
Why?
| | Joints | 1 | 2020 | 84 | 0.810 |
Why?
| | CD4-Positive T-Lymphocytes | 4 | 2020 | 1063 | 0.800 |
Why?
| | Leishmania major | 1 | 2018 | 5 | 0.770 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 8 | 0.770 |
Why?
| | Aging | 2 | 2019 | 1711 | 0.740 |
Why?
| | Mental Recall | 1 | 2019 | 216 | 0.720 |
Why?
| | Virulence Factors | 1 | 2018 | 132 | 0.690 |
Why?
| | Superoxide Dismutase | 1 | 2018 | 346 | 0.650 |
Why?
| | Cytokines | 3 | 2020 | 1974 | 0.590 |
Why?
| | Mice | 17 | 2021 | 15510 | 0.490 |
Why?
| | Mice, Inbred C57BL | 12 | 2021 | 5232 | 0.470 |
Why?
| | Macrophages | 1 | 2018 | 1338 | 0.440 |
Why?
| | Animals | 23 | 2022 | 35194 | 0.420 |
Why?
| | Receptors, Immunologic | 2 | 2021 | 212 | 0.390 |
Why?
| | Adaptive Immunity | 3 | 2020 | 174 | 0.390 |
Why?
| | Peromyscus | 2 | 2004 | 9 | 0.360 |
Why?
| | Mice, Inbred BALB C | 3 | 2020 | 1326 | 0.360 |
Why?
| | Mice, Knockout | 5 | 2020 | 2888 | 0.330 |
Why?
| | Antiviral Agents | 2 | 2021 | 635 | 0.280 |
Why?
| | Ross River virus | 2 | 2021 | 23 | 0.270 |
Why?
| | Virulence | 3 | 2021 | 247 | 0.270 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 3 | 2014 | 323 | 0.270 |
Why?
| | Mice, Transgenic | 6 | 2021 | 2159 | 0.260 |
Why?
| | Disease Models, Animal | 5 | 2020 | 3892 | 0.260 |
Why?
| | Kupffer Cells | 2 | 2021 | 53 | 0.260 |
Why?
| | Lectins, C-Type | 2 | 2020 | 75 | 0.250 |
Why?
| | Interferon Type I | 2 | 2021 | 130 | 0.250 |
Why?
| | Lymphoid Tissue | 2 | 2019 | 63 | 0.250 |
Why?
| | Viremia | 1 | 2021 | 125 | 0.220 |
Why?
| | Receptors, Mitogen | 1 | 2020 | 7 | 0.220 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2021 | 400 | 0.210 |
Why?
| | Immunization | 2 | 2020 | 396 | 0.210 |
Why?
| | O'nyong-nyong Virus | 1 | 2019 | 4 | 0.210 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 23 | 0.210 |
Why?
| | Adoptive Transfer | 1 | 2020 | 235 | 0.200 |
Why?
| | Arthritis | 1 | 2020 | 109 | 0.200 |
Why?
| | Leishmania donovani | 1 | 2018 | 5 | 0.190 |
Why?
| | Parasite Load | 1 | 2018 | 9 | 0.190 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2628 | 0.190 |
Why?
| | Viral Envelope Proteins | 1 | 2019 | 89 | 0.190 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 22 | 0.190 |
Why?
| | Gene Deletion | 2 | 2018 | 387 | 0.180 |
Why?
| | Antigens, Viral | 1 | 2018 | 184 | 0.180 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2018 | 77 | 0.180 |
Why?
| | Acute Disease | 1 | 2020 | 997 | 0.170 |
Why?
| | Virus Replication | 1 | 2020 | 432 | 0.170 |
Why?
| | Dendritic Cells | 1 | 2021 | 489 | 0.170 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2019 | 837 | 0.170 |
Why?
| | Antibodies, Viral | 1 | 2020 | 512 | 0.160 |
Why?
| | TRPM Cation Channels | 2 | 2008 | 73 | 0.160 |
Why?
| | Cells, Cultured | 4 | 2018 | 4413 | 0.160 |
Why?
| | T-Lymphocyte Subsets | 2 | 2011 | 451 | 0.150 |
Why?
| | Cell Survival | 1 | 2018 | 1185 | 0.140 |
Why?
| | Monocytes | 1 | 2017 | 513 | 0.140 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 606 | 0.140 |
Why?
| | Chronic Disease | 1 | 2020 | 1666 | 0.140 |
Why?
| | Cell Movement | 1 | 2018 | 930 | 0.130 |
Why?
| | Acute Lung Injury | 1 | 2017 | 325 | 0.130 |
Why?
| | Insulin-Secreting Cells | 1 | 2018 | 339 | 0.130 |
Why?
| | Vaccination | 1 | 2021 | 932 | 0.130 |
Why?
| | Glucose | 1 | 2018 | 866 | 0.130 |
Why?
| | Nuclear Proteins | 1 | 2018 | 648 | 0.130 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1294 | 0.120 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2013 | 178 | 0.120 |
Why?
| | Male | 6 | 2020 | 60721 | 0.110 |
Why?
| | Neutrophils | 1 | 2017 | 1322 | 0.110 |
Why?
| | MicroRNAs | 1 | 2017 | 626 | 0.110 |
Why?
| | Epithelial Cells | 1 | 2017 | 1034 | 0.110 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1407 | 0.110 |
Why?
| | T-Lymphocytes | 3 | 2019 | 1843 | 0.100 |
Why?
| | Immunodominant Epitopes | 1 | 2009 | 28 | 0.100 |
Why?
| | Transcription Factors | 1 | 2018 | 1636 | 0.100 |
Why?
| | Mutant Proteins | 1 | 2008 | 105 | 0.090 |
Why?
| | Parkinsonian Disorders | 1 | 2008 | 41 | 0.090 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2008 | 60 | 0.090 |
Why?
| | Lymphocyte Activation | 2 | 2018 | 1165 | 0.080 |
Why?
| | Viral Load | 2 | 2021 | 470 | 0.080 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2004 | 165 | 0.080 |
Why?
| | RNA, Viral | 2 | 2021 | 589 | 0.080 |
Why?
| | Cloning, Molecular | 2 | 2004 | 598 | 0.080 |
Why?
| | Killer Cells, Natural | 2 | 2019 | 386 | 0.080 |
Why?
| | Immune Sera | 1 | 2004 | 81 | 0.070 |
Why?
| | Hemocyanins | 1 | 2004 | 76 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2009 | 734 | 0.070 |
Why?
| | Antigen-Presenting Cells | 1 | 2004 | 170 | 0.070 |
Why?
| | Insulin | 2 | 2018 | 2167 | 0.070 |
Why?
| | Lung | 1 | 2017 | 3587 | 0.070 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2004 | 139 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2004 | 403 | 0.060 |
Why?
| | B-Lymphocytes | 2 | 2019 | 830 | 0.060 |
Why?
| | Female | 3 | 2020 | 62627 | 0.060 |
Why?
| | Bone Marrow Cells | 1 | 2004 | 330 | 0.060 |
Why?
| | Antigen Presentation | 1 | 2004 | 218 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2004 | 382 | 0.060 |
Why?
| | Alphavirus | 1 | 2021 | 16 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 2919 | 0.060 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 312 | 0.060 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 60 | 0.050 |
Why?
| | Humans | 12 | 2022 | 112255 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2018 | 2400 | 0.050 |
Why?
| | Viral Tropism | 1 | 2019 | 28 | 0.050 |
Why?
| | Cricetinae | 1 | 2020 | 293 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 204 | 0.050 |
Why?
| | Disease Outbreaks | 1 | 2022 | 281 | 0.050 |
Why?
| | Venules | 1 | 2018 | 14 | 0.050 |
Why?
| | Chemokine CCL21 | 1 | 2018 | 15 | 0.050 |
Why?
| | Organelle Biogenesis | 1 | 2018 | 13 | 0.050 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 316 | 0.050 |
Why?
| | Interferon Regulatory Factor-7 | 1 | 2017 | 5 | 0.050 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2017 | 9 | 0.050 |
Why?
| | Conserved Sequence | 2 | 2009 | 226 | 0.050 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2017 | 15 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 73 | 0.050 |
Why?
| | Ovalbumin | 1 | 2018 | 190 | 0.050 |
Why?
| | Mitochondrial Dynamics | 1 | 2018 | 28 | 0.050 |
Why?
| | Antigens, Ly | 1 | 2017 | 47 | 0.050 |
Why?
| | Stromal Cells | 1 | 2018 | 118 | 0.040 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 34 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 24 | 0.040 |
Why?
| | Diphtheria Toxin | 1 | 2017 | 69 | 0.040 |
Why?
| | Lysine | 1 | 2019 | 229 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2019 | 324 | 0.040 |
Why?
| | Cadaver | 1 | 2018 | 269 | 0.040 |
Why?
| | Spleen | 1 | 2019 | 558 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 102 | 0.040 |
Why?
| | Luminescent Proteins | 1 | 2018 | 183 | 0.040 |
Why?
| | Protein Subunits | 1 | 2018 | 238 | 0.040 |
Why?
| | Magnesium | 2 | 2008 | 153 | 0.040 |
Why?
| | Cell Degranulation | 1 | 2016 | 38 | 0.040 |
Why?
| | Granzymes | 1 | 2016 | 30 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 321 | 0.040 |
Why?
| | Epitopes | 1 | 2018 | 428 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2021 | 641 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2016 | 218 | 0.040 |
Why?
| | RNA Interference | 1 | 2018 | 514 | 0.040 |
Why?
| | Cell Communication | 1 | 2017 | 285 | 0.040 |
Why?
| | Cellular Senescence | 1 | 2016 | 147 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2018 | 663 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2018 | 693 | 0.040 |
Why?
| | Mutation | 2 | 2021 | 3421 | 0.040 |
Why?
| | V(D)J Recombination | 1 | 2014 | 5 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2021 | 758 | 0.040 |
Why?
| | Nanoparticles | 1 | 2017 | 337 | 0.030 |
Why?
| | Thymus Gland | 1 | 2014 | 289 | 0.030 |
Why?
| | Cell Membrane | 2 | 2008 | 770 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2009 | 3262 | 0.030 |
Why?
| | Pneumonia | 1 | 2017 | 557 | 0.030 |
Why?
| | B7-2 Antigen | 1 | 2011 | 30 | 0.030 |
Why?
| | Viruses | 1 | 2013 | 89 | 0.030 |
Why?
| | CD28 Antigens | 1 | 2011 | 49 | 0.030 |
Why?
| | B7-1 Antigen | 1 | 2011 | 65 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2008 | 2228 | 0.030 |
Why?
| | Transcriptome | 1 | 2016 | 680 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2008 | 3120 | 0.030 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2009 | 46 | 0.020 |
Why?
| | Amino Acids, Diamino | 1 | 2008 | 1 | 0.020 |
Why?
| | Guam | 1 | 2008 | 3 | 0.020 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2008 | 8 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2009 | 58 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1184 | 0.020 |
Why?
| | Hybridomas | 1 | 2009 | 251 | 0.020 |
Why?
| | Proline | 1 | 2008 | 74 | 0.020 |
Why?
| | Ion Channel Gating | 1 | 2008 | 94 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 1824 | 0.020 |
Why?
| | Leucine | 1 | 2008 | 111 | 0.020 |
Why?
| | Rats | 1 | 2018 | 6372 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2009 | 554 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2008 | 311 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 4914 | 0.020 |
Why?
| | Bacteria | 1 | 2013 | 670 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2008 | 236 | 0.020 |
Why?
| | Inflammation | 1 | 2017 | 2427 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2005 | 72 | 0.020 |
Why?
| | Autoantigens | 1 | 2009 | 411 | 0.020 |
Why?
| | Temperature | 1 | 2008 | 665 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 2008 | 454 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2004 | 298 | 0.020 |
Why?
| | Cell Division | 1 | 2005 | 880 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2004 | 371 | 0.020 |
Why?
| | Models, Molecular | 1 | 2008 | 1603 | 0.020 |
Why?
| | Protein Binding | 1 | 2009 | 2112 | 0.020 |
Why?
| | Calcium | 1 | 2008 | 1215 | 0.010 |
Why?
| | Interleukins | 1 | 2004 | 235 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2008 | 1237 | 0.010 |
Why?
| | Homeostasis | 1 | 2005 | 595 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 1125 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1740 | 0.010 |
Why?
| | Cell Line | 1 | 2005 | 3013 | 0.010 |
Why?
|
|
Davenport's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|